Literature DB >> 304947

Early and late results of resection of ventricular aneurysm.

J E Okies, C Dietl, H B Garrison, A Starr.   

Abstract

Fifty-seven patients have undergone ventricular aneurysm resection with a mortality rate of 10 percent. Recent surgical trends have been toward complete revascularization and treatment of concomitant disorders when present. Although the early mortality rate may be favorable influenced by these maneuvers, analysis of survivors reveals no significant difference in survival between the group that had concomitant coronary artery bypass and the group that had aneurysm resection alone (84 percent versus 78 percent). There were significantly more asymptomatic patients in the revascularized group, however (74 percent versus 53 percent). Analysis of hospital deaths revealed nearly all to be seconary to low output syndrome, arrhythmia, myocardial infarction, or a combination of the three. Late death was due to either congestive heart failure or a myocardial infarction in all but one case. Seventy-seven percent of operative survivors are asymptomatic. Late morbidity is usually related to ungrafted or progressive coronary artery disease and generally has been successfully managed by reoperation.

Entities:  

Mesh:

Year:  1978        PMID: 304947

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Management of ventricular aneurysms following myocardial infarction.

Authors:  W A Gay
Journal:  World J Surg       Date:  1978-11       Impact factor: 3.352

2.  The influence of cardiac geometry on the results of ventricular aneurysm repair.

Authors:  G M Hutchins; R K Brawley
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

3.  Left ventricular aneurysm: Twenty-year surgical experience with 1572 patients at the Texas Heart Institute.

Authors:  Sitaram B. Reddy; Denton A. Cooley; J Michael Duncan; John C. Norman
Journal:  Cardiovasc Dis       Date:  1981-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.